Cargando…
Stapled Peptides Inhibitors: A New Window for Target Drug Discovery
Protein-protein interaction (PPI) is a hot topic in clinical research as protein networking has a major impact in human disease. Such PPIs are potential drugs targets, leading to the need to inhibit/block specific PPIs. While small molecule inhibitors have had some success and reached clinical trial...
Autores principales: | Ali, Ameena M., Atmaj, Jack, Van Oosterwijk, Niels, Groves, Matthew R., Dömling, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396041/ https://www.ncbi.nlm.nih.gov/pubmed/30867891 http://dx.doi.org/10.1016/j.csbj.2019.01.012 |
Ejemplares similares
-
A Systematic Protein Refolding Screen Method using the DGR Approach Reveals that Time and Secondary TSA are Essential Variables
por: Wang, Yuanze, et al.
Publicado: (2017) -
Structure‐Enabled Discovery of a Stapled Peptide Inhibitor to Target the Oncogenic Transcriptional Repressor TLE1
por: McGrath, Sally, et al.
Publicado: (2017) -
Covalent inhibitors: a rational approach to drug discovery
por: Sutanto, Fandi, et al.
Publicado: (2020) -
Discovery of Small-Molecule
Allosteric Inhibitors
of PfATC as Antimalarials
por: Wang, Chao, et al.
Publicado: (2022) -
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer
por: Mitra, Shreya, et al.
Publicado: (2017)